IE810715L - Cisplatin solution - Google Patents

Cisplatin solution

Info

Publication number
IE810715L
IE810715L IE810715A IE71581A IE810715L IE 810715 L IE810715 L IE 810715L IE 810715 A IE810715 A IE 810715A IE 71581 A IE71581 A IE 71581A IE 810715 L IE810715 L IE 810715L
Authority
IE
Ireland
Prior art keywords
polyethylene glycol
cisplatin solution
cisplatin
gb2074028a
solvent
Prior art date
Application number
IE810715A
Other versions
IE51070B1 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IE810715L publication Critical patent/IE810715L/en
Publication of IE51070B1 publication Critical patent/IE51070B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

There are provided stable concentrated solutions of cisplatin in a solvent comprising polyethylene glycol or methoxy polyethylene glycol, or a mixture thereof, plus water and a nontoxic pharmaceutically acceptable source of chloride ion. [GB2074028A]
IE715/81A 1980-03-31 1981-03-30 Pharmaceutical formulations comprising cisplatatin solutions IE51070B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
IE810715L true IE810715L (en) 1981-09-30
IE51070B1 IE51070B1 (en) 1986-09-17

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
IE715/81A IE51070B1 (en) 1980-03-31 1981-03-30 Pharmaceutical formulations comprising cisplatatin solutions

Country Status (30)

Country Link
JP (1) JPS56152415A (en)
KR (1) KR860000841B1 (en)
AR (1) AR225500A1 (en)
AT (1) AT370996B (en)
AU (1) AU541056B2 (en)
BE (1) BE888209A (en)
CA (1) CA1162479A (en)
CH (1) CH647481A5 (en)
CS (1) CS246051B2 (en)
DD (1) DD157762A5 (en)
DE (1) DE3112272A1 (en)
DK (1) DK158564C (en)
ES (1) ES500869A0 (en)
FI (1) FI70670C (en)
FR (1) FR2480605A1 (en)
GB (1) GB2074028B (en)
GR (1) GR72769B (en)
HU (1) HU183379B (en)
IE (1) IE51070B1 (en)
IL (1) IL62517A (en)
IT (1) IT1170838B (en)
LU (1) LU83270A1 (en)
NL (1) NL8101531A (en)
NO (1) NO156675C (en)
NZ (1) NZ196519A (en)
PH (1) PH17152A (en)
PT (1) PT72774B (en)
SE (1) SE455045B (en)
SU (1) SU1056893A3 (en)
ZA (1) ZA812084B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (en) * 1982-09-23 1987-01-21 Erba Farmitalia PHARMACOLOGICAL COMPOSITIONS BASED ON CISPLATIN AND METHOD FOR THEIR OBTAINMENT
NL8303657A (en) * 1983-10-24 1985-05-17 Pharmachemie Bv SOLUTION, STABLE, AQUEOUS, AQUEOUS, CONTAINING SOLUTION OF CISPLATINE, AND METHOD OF PREPARING THEREOF.
FI895340A0 (en) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co HYPERTONISK CISPLATIN-LOESNING.
JP2001501173A (en) * 1996-08-23 2001-01-30 アルザ コーポレイション Liposomes containing cisplatin compounds
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (en) 2004-03-26 2010-04-07 オンキヨー株式会社 Switching amplifier
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
US11752135B2 (en) 2018-03-29 2023-09-12 Project Pharmaceutics Gmbh Liquid pharmaceutical formulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (en) * 1978-05-30 1986-06-09 Bristol Myers Co STABLE, STERILE WATER DISPOSAL OF CISPLATIN IN UNIT DOSAGE FORM

Also Published As

Publication number Publication date
NO156675B (en) 1987-07-27
PH17152A (en) 1984-06-13
JPS6360008B2 (en) 1988-11-22
IL62517A (en) 1984-01-31
SE8101990L (en) 1981-11-13
SE455045B (en) 1988-06-20
CS246051B2 (en) 1986-10-16
KR860000841B1 (en) 1986-07-09
IE51070B1 (en) 1986-09-17
BE888209A (en) 1981-09-30
SU1056893A3 (en) 1983-11-23
FR2480605B1 (en) 1984-05-11
NO811081L (en) 1981-10-01
NZ196519A (en) 1983-06-17
GR72769B (en) 1983-12-02
JPS56152415A (en) 1981-11-26
FI810934L (en) 1981-10-01
FI70670B (en) 1986-06-26
NL8101531A (en) 1981-10-16
HU183379B (en) 1984-04-28
ES8206545A1 (en) 1982-08-16
DK158564C (en) 1990-11-05
DK144281A (en) 1981-10-01
ATA150481A (en) 1982-10-15
ES500869A0 (en) 1982-08-16
GB2074028A (en) 1981-10-28
GB2074028B (en) 1983-09-21
FI70670C (en) 1986-10-06
DE3112272A1 (en) 1982-04-29
AR225500A1 (en) 1982-03-31
AT370996B (en) 1983-05-25
KR830004849A (en) 1983-07-20
IL62517A0 (en) 1981-05-20
PT72774A (en) 1981-04-01
PT72774B (en) 1982-11-16
IT1170838B (en) 1987-06-03
AU6816681A (en) 1981-10-08
ZA812084B (en) 1982-04-28
CA1162479A (en) 1984-02-21
LU83270A1 (en) 1981-10-29
DD157762A5 (en) 1982-12-08
AU541056B2 (en) 1984-12-13
NO156675C (en) 1987-11-04
DE3112272C2 (en) 1990-09-27
DK158564B (en) 1990-06-11
CH647481A5 (en) 1985-01-31
IT8148090A0 (en) 1981-03-24
FR2480605A1 (en) 1981-10-23

Similar Documents

Publication Publication Date Title
DE3370589D1 (en) Dialysis solutions containing bicarbonate ions
AU558104B2 (en) Atmospheric oxygen cell
AU5092185A (en) Osmotic concentration by membrane
AU6785087A (en) Porous polyolefin films
AU590691B2 (en) 2-azolylmethyl-2-aryl-1, 3-dioxolanes and the salts thereof,processes for the preparation thereof,agents containing same,and the use thereof
AU561698B2 (en) Phenotiazone derivatives and their o,n and se analogues
IE810715L (en) Cisplatin solution
AU1535583A (en) Puzzle post toy
AU590882B2 (en) Polymer solutions
AU7694081A (en) Benzoxazine,isoindole derivatives
AU1319183A (en) Perfluorocarbon copolymer films
EP0457960A3 (en) High acid concentration dialysates
USD273412S (en) Water purification ionic gas generator
FI864548A (en) HEXAHYDRO- (1) -BENO- (PYRANO OCH THIOPYRANO) (4,3-C) PYRIDINER.
GB2188900B (en) Fusogenic phospholipid vesicles.
AU550096B2 (en) Dibenzo-1,4-dioxepins and their thia analogues
AU5299379A (en) 4,1-benzoxazepines and thia analogues
AU5565180A (en) Acrylate-vinyl lactam polymer blend
FI863958A (en) DELAT GLIDLAGER, I SYNNERHET FOER VAEVAXEL FOER MEDELSTORA OCH STORA MOTORER.
AU590400B2 (en) 2-azolylmethyl-2-aryl-1, 3-dioxolanes and the salts thereof, processes for the preparation thereof, agents containing same, and the use thereof
USD273696S (en) Water purification ionic gas generator
DE3373480D1 (en) Peptide derivatives, their production and use
AU7406681A (en) Concentration of aqueous glycol solutions
FI843998L (en) THERMORE REACTIVE MAERKNINGSMEDEL, DESS ANVAENDNING, OCH ANVAENDNING AV SYRAMODIFIERADE POLYMERATER SOM ACCEPTORER I DYLIKA MAERKNINGSAEMNEN.
USD273411S (en) Water purification ionic gas generator

Legal Events

Date Code Title Description
MM4A Patent lapsed